Diabetic Ketoacidosis Revealing Adult Cystic Fibrosis Associated with Graves' Disease: About One Case

Lakrafi Yassir *

Department of Internal Medicine and Geriatrics Unit of the Ibn Rochd University Hospital Center in Casablanca, Morocco and Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Morocco.

Barakat Leila

Department of Internal Medicine and Geriatrics Unit of the Ibn Rochd University Hospital Center in Casablanca, Morocco and Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Morocco.

Benzakour Merieme

Department of Internal Medicine and Geriatrics Unit of the Ibn Rochd University Hospital Center in Casablanca, Morocco and Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Morocco.

Echchilali Khadija

Department of Internal Medicine and Geriatrics Unit of the Ibn Rochd University Hospital Center in Casablanca, Morocco and Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Morocco.

Moudatir Mina

Department of Internal Medicine and Geriatrics Unit of the Ibn Rochd University Hospital Center in Casablanca, Morocco and Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Morocco.

Hassan ElKabli

Department of Internal Medicine and Geriatrics Unit of the Ibn Rochd University Hospital Center in Casablanca, Morocco and Faculty of Medicine and Pharmacy of Casablanca, Hassan II University, Morocco.

*Author to whom correspondence should be addressed.


Abstract

Cystic fibrosis is most often diagnosed in the first years of life due to pancreatic insufficiency and respiratory damage with chronic bronchial suppuration. However, moderate or monosymptomatic forms may only appear in adulthood. As for Graves' disease, it is an autoimmune pathology causing hyperthyroidism, its most characterising manifestation being a homogeneous goiter. It preferentially affects relatively young women, but can occur at any age. The association of cystic fibrosis and Graves' disease is a possibility described in the medical literature and that our case illustrates, this association can be fatal when cystic fibrosis is responsible for diabetes at the insulin deficiency stage and the latter is associated to hyperthyroidism canceling out any effect of insulin treatment, thus endangering its vital prognosis.

Keywords: Diabetic ketoacidosis, cystic fibrosis, genetic disease


How to Cite

Yassir, L., Leila, B., Merieme, B., Khadija, E., Mina, M., & ElKabli, H. (2024). Diabetic Ketoacidosis Revealing Adult Cystic Fibrosis Associated with Graves’ Disease: About One Case. Asian Journal of Case Reports in Medicine and Health, 7(1), 51–57. Retrieved from https://journalajcrmh.com/index.php/AJCRMH/article/view/186

Downloads

Download data is not yet available.

References

Cystic Fibrosis Kimberly M. Dickinson, Joseph M. Collaco. Johns Hopkins University, School of Medicine, Eudowood Division of Pediatric Respiratory Sciences, Baltimore, MD Pediatr Rev. 2021;42(2): 55–67. DOI: 10.1542/pir.2019-0212

Pneumologie/Pulmonary and Respiratory Medicine Mucoviscidose Cystic fibrosis D. Hubert (Hospital practitioner) Pneumology Department, Cochin Hospital, 27, rue du faubourg Saint-Jacques, 75679 Paris cedex 14, France

Clinical Phenotypes of Cystic Fibrosis Carriers Philip M Polgreen, Alejandro P Comellas. Division of Infectious Diseases, Department of Internal Medicine, University of Iowa, Iowa City, Iowa 52242, USA 2Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Iowa, Iowa City, Iowa 52242, USA Annu Rev Med. 2022; 73:563–574. DOI:10.1146/annurev-med-042120-020148.

Diagnosing Cystic Fibrosis in Adults Peter J. Barry. Manchester Adult Cystic Fibrosis Centre, Manchester University National Health Service Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom Nicholas J. Simmonds 2 Adult Cystic Fibrosis Centre, Royal Brompton Hospital, London, United Kingdom 3 National Heart and Lung Institute, Imperial College London, London, United Kingdom Semin Respir Crit Care Med. 2023;44(02):242-251. DOI: 10.1055/s-0042-1759881

Graves' disease: Epidemiological, clinical and therapeutic study: about 40 cases Dr Ali S, Elajmi W, Pr H. Hammami Tunis Military Hospital, Tunis, Tunisia SFE Marseille 2020 / Annales d'Endocrinologie. 2020;81:315–350

Journal of Clinical Medicine Case Report Concomitant Use of Elexacaftor/ Tezacaftor/Ivacaftor and Etanercept in a Cystic Fibrosis Patient with Juvenile Idiopathic Arthritis Sara Immacolata Orsini 1,†, Edoardo Marrani 2,* ,† , Ilaria Pagnini 2, Giovanni Taccetti 3 , Vito Terlizzi 3 and Gabriele Simonini 2 1 Department of Woman, Child and of General and Specialized Surgery, Università degli Studi della Campania “Luigi Vanvitelli”, 80138 Naples, Italy 2 Pediatric Rheumatology Unit, Meyer Children's Hospital IRCCS, 50139 Florence, Italy 3 Department of Pediatric Medicine, Meyer Children's Hospital IRCCS, Cystic Fibrosis Regional Reference Center, 50139 Florence, Italy.

Yu-Shan Hsieh. Safety of antithyroid drugs in avoiding hyperglycemia or hypoglycemia in patients with graves’ disease and type 2 diabetes mellitus: A literature review. School of Nursing, National Taipei University of Nursing and Health Sciences, Taipei City, TWN 2. Department of Research, Taipei Medical University Hospital, Taipei City, TWN Corresponding author: Yu-Shan Hsieh, Hsieh et al. Cureus. 2023 ;15(6):e41017. DOI : 10.7759/cureus.41017